Population-based analysis of the epidemiology of the surgical correction of hyperhidrosis in 1,216 patients over 11 years
a cross-sectional study
Palavras-chave:
Sympathectomy, Big data, Public healthResumo
BACKGROUND: Endoscopic thoracic sympathectomy is the definitive surgical treatment for hyperhidrosis and a nationwide study has suggested that cultural and socioeconomic factors play a role in the numbers of operations performed. Thus, there is a need to evaluate local data in order to understand the local epidemiology and trends in hyperhidrosis treatment. OBJECTIVE: To study the epidemiology of sympathectomy for treating hyperhidrosis in São Paulo, the largest city in Brazil. DESIGN AND SETTING: Population-based retrospective cross-sectional study. METHODS: Data on sympathectomies for treating hyperhidrosis between 2008 and 2018 were assessed from the database of the Municipal Health Department of São Paulo, Brazil.RESULTS: 65.29% of the patients were female, 66.2% were aged between 20 and 39 years and 37.59% had registered with addresses outside São Paulo. 1,216 procedures were performed in the city of São Paulo from 2008 to 2018, and 78.45% of them were in only two public hospitals. The number of procedures significantly declined over the years (P = 0.001). 71.63% of the procedures were associated with 2-3 days of hospital stay, only 78 intensive care unit days were billed and we did not observe any intra-hospital death. CONCLUSION: The profile of patients operated on in São Paulo (young women) is similar to that described in other populations. Sympathectomy is a very safe procedure, with no mortality in our series. There was a decreasing trend in the number of surgeries over the years.
Downloads
Referências
de Moura Júnior NB, das-Neves-Pereira JC, de Oliveira FRG, et al. Expression of Acetylcholine and Its Receptor in Human Sympathetic Ganglia in Primary Hyperhidrosis. Ann Thorac Surg. 2013;95(2):465-70. PMID: 23219256; https://doi.org/10.1016/j.athoracsur.2012.10.068.
Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: Results from a national survey. J Am Acad Dermatol. 2004;51(2):241-8. PMID: 15280843; https://doi.org/10.1016/j.jaad.2003.12.040.
Doolittle J, Walker P, Mills T, Thurston J. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743-9. PMID: 27744497; https://doi.org/10.1007/s00403-016-1697-9.
Cerfolio RJ, De Campos JRM, Bryant AS, et al. The Society of Thoracic Surgeons Expert Consensus for the Surgical Treatment of Hyperhidrosis. Ann Thorac Surg. 2011;91(5):1642-8. PMID: 21524489; https://doi.org/10.1016/j.athoracsur.2011.01.105.
Lear W, Kessler E, Solish N, Glaser DA. An epidemiological study of hyperhidrosis. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2007;33(1 Spec No.):S69-75. PMID: 17241417; https://doi.org/10.1111/j.1524-4725.2006.32334.x.
Wolosker N, de Campos JR, Kauffman P, et al. Evaluation of quality of life over time among 453 patients with hyperhidrosis submitted to endoscopic thoracic sympathectomy. J Vasc Surg. 2012;55(1):154-6. PMID: 22047833; https://doi.org/10.1016/j.jvs.2011.07.097.
Menna C, Ibrahim M, Andreetti C, et al. Long term compensatory sweating results after sympathectomy for palmar and axillary hyperhidrosis. Ann Cardiothorac Surg. 2016;5(1):26-32. PMID: 26904428; https://doi.org/10.3978/j.issn.2225-319X.2015.12.01.
Louzada ACS, da Silva MFA, Portugal MFC, et al. Nationwide Cross-Sectional Analysis of Endoscopic Thoracic Sympathectomy to Treat Hyperhidrosis over 12 years in Brazil: Epidemiology, Costs and Mortality. Ann Surg. 2021. Epub ahead of print. PMID: 34417365; https://doi.org/10.1097/SLA.0000000000005178.
Instituto Brasileiro de Geografia e Estatística. Painel de Indicadores. 2021. Available from: https://www.ibge.gov.br/indicadores.html Accessed in 2021 (Nov 30).
Ministério da Saúde do Brasil. Agência Nacional de Saúde Suplementar. Available from: https://www.gov.br/ans/pt-br Accessed in 2021 (Nov 30).
Secretaria Municipal de Saúde de São Paulo. TabNet Win32 3.0: Internações SUS. DATASUS. Available from: http://tabnet.saude.sp.gov.br/deftohtm.exe?tabnet/aih_rd2008.def Accessed in 2021 (Nov 30).
Wolosker N, Munia MAS, Kauffman P, et al. Is gender a predictive factor for satisfaction among patients undergoing sympathectomy to treat palmar hyperhidrosis? Clinics (Sao Paulo). 2010;65(6):583-6. PMID: 20613933; https://doi.org/10.1590/S1807-59322010000600004.
Haider A, Solish N. Focal hyperhidrosis: diagnosis and management. CMAJ. 2005;172(1):69-75. PMID: 15632408; https://doi.org/10.1503/cmaj.1040708.
Sammons JE, Khachemoune A. Axillary hyperhidrosis: a focused review. J Dermatol Treat. 2017;28(7):582-90. PMID: 28318360; https://doi.org/10.1080/09546634.2017.1309347.
Estevan FA, Wolosker MB, Wolosker N, Puech-Leão P. Epidemiologic analysis of prevalence of the hyperhidrosis. An Bras Dermatol. 2017;92(5):630-4. PMID: 29166497; https://doi.org/10.1590/abd1806-4841.20175551.
González López SL, Díaz Juárez M, Cabrera Machado CA, et al. Video-assisted thoracoscopic treatment for two ports for idiopathic palmar and axillary hyperhidrosis in children. Cir Pediatr. 2019;32(3):115-20. PMID: 31486302.
Faustino CB, Milanez de Campos JR, Kauffman P, et al. Analysis of the Results of Videotoracoscopic Sympathectomy in the Treatment of Hyperhidrosis in Patients 40 Years or Older. Ann Vasc Surg. 2020;65:107-12. PMID: 31494263; https://doi.org/10.1016/j.avsg.2019.04.024.
Stabellini N, Wolosker N, Leiderman DBD, et al. Epidemiological Analysis of Carotid Artery Stenosis Intervention during 10 years in the Public Health System in the Largest City in Brazil: Stenting Has Been More Common than Endarterectomy. Ann Vasc Surg. 2020;66:378-84. PMID: 31931132; https://doi.org/10.1016/j.avsg.2019.12.040.
Tribunal de Contas do Estado de São Paulo. Painel da Saúde - Hospitais. Available from: https://painel.tce.sp.gov.br/pentaho/api/repos/%3Apublic%3ApainelSaude%3ApainelSaude.wcdf/generatedContent?userid=anony&password=zero. Accessed in 2021 (Nov 30).
Regionalização no Sistema Único de Saúde - Posicionamento e Orientações. Conselho Nacional de Secretarias Municipais de Saúde. Available from: https://www.conasems.org.br/wp-content/uploads/2019/02/Documento-T%C3%A9cnico-regionaliza%C3%A7%C3%A3o-DIAGRAMADO-FINAL-1.pdf Accessed in 2021 (Nov 30).
Chwajol M, Barrenechea IJ, Chakraborty S, et al. Impact of compensatory hyperhidrosis on patient satisfaction after endoscopic thoracic sympathectomy. Neurosurgery. 2009;64(3):511-8. PMID: 19240613; https://doi.org/10.1227/01.NEU.0000339128.13935.0E.
Lin TS, Fang HY. Transthoracic endoscopic sympathectomy in the treatment of palmar hyperhidrosis—with emphasis on perioperative management (1,360 case analyses). Surg Neurol. 1999;52(5):453-7. PMID: 10595764; https://doi.org/10.1016/s0090-3019(99)00111-1.
Wolosker N, Milanez de Campos JR, Fukuda JM. Management of Compensatory Sweating After Sympathetic Surgery. Thorac Surg Clin. 2016;26(4):445-51. PMID: 27692203; https://doi.org/10.1016/j.thorsurg.2016.06.009.
Yazbek G, Ishy A, Alexandrino da Silva MF, et al. Evaluation of compensatory hyperhidrosis after sympathectomy: the use of an objective method. Ann Vasc Surg. 2021;S08905096(21)004799. PMID: 34411664; https://doi.org.10.1016/j.avsg.2021.05.014
Wolosker N, de Campos JR, Kauffman P, et al. An alternative to treat palmar hyperhidrosis: use of oxybutynin. Clin Auton Res. 2011;21(6):389-93. PMID: 21688168; https://doi.org/10.1007/s10286-011-0128-4.
Wolosker N, Teivelis MP, Krutman M, et al. Long-Term Efficacy of Oxybutynin for Palmar and Plantar Hyperhidrosis in Children Younger than 14 Years. Pediatr Dermatol. 2015;32(5):663-7. PMID: 25490865; https://doi.org/10.1111/pde.12385.
Wolosker N, Teivelis MP, Krutman M, et al. Long-term Results of the Use of Oxybutynin for the Treatment of Axillary Hyperhidrosis. Ann Vasc Surg. 2014;28(5):1106-12. PMID: 24512855; https://doi.org/10.1016/j.avsg.2013.12.024.
Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin treatment for palmar hyperhidrosis. Clin Auton Res. 2014;24(6):297-303. PMID: 25427685; https://doi.org/10.1007/s10286-014-0264-8.
Wolosker N, Teivelis MP, Krutman M, et al. Long-term results of oxybutynin use in treating facial hyperhidrosis. An Bras Dermatol. 2014;89(6):912-6. PMID: 25387496; https://doi.org/10.1590/abd1806-4841.20143272.
Wolosker N, Krutman M, Kauffman P, Paula RP, Campos JR, Puech-Leão P. Effectiveness of oxybutynin for treatment of hyperhidrosis in overweight and obese patients. Rev Assoc Med Bras (1992). 2013;59(2):143-7. PMID: 23582555; https://doi.org/10.1016/j.ramb.2012.11.002.
Wolosker N, Krutman M, Campdell TP, et al. Oxybutynin treatment for hyperhidrosis: a comparative analysis between genders. Einstein (Sao Paulo). 2012;10(4):405-8. PMID: 23386077; https://doi.org/10.1590/s1679-45082012000400002.
Gossot D, Kabiri H, Caliandro R, et al. Early complications of thoracic endoscopic sympathectomy: a prospective study of 940 procedures. Ann Thorac Surg. 2001;71(4):1116-9. PMID: 11308146; https://doi.org/10.1016/s0003-4975(01)02422-5.
Kuijpers M, Klinkenberg TJ, Bouma W, DeJongste MJ, Mariani MA. Single-port one-stage bilateral thoracoscopic sympathicotomy for severe hyperhidrosis: prospective analysis of a standardized approach. J Cardiothorac Surg. 2013;8(1):216. PMID: 24279511; https://doi.org/10.1186/1749-8090-8-216.
Castro MC, Massuda A, Almeida G, et al. Brazil’s unified health system: the first 30 years and prospects for the future. Lancet. 2019;394(10195):345-56. PMID: 31303318; https://doi.org/10.1016/S0140-6736(19)31243-7.
Isla-Tejera B, Ruano J, Alvarez MA, et al. Economic Evaluation of Botulinum Toxin Versus Thoracic Sympathectomy for Palmar Hyperhidrosis: Data from a Real-World Scenario. Dermatol Ther (Heidelb). 2013;3(1):63-72. PMID: 23888256; https://doi.org/10.1007/s13555-013-0025-y.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
